| Tretinoin | Approved Investigational Nutraceutical | EBF1 | 1879 |
upregulated | Tretinoin results in increased expression of EBF1 mRNA | 5q33.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EBNA1BP2 | 10969 |
downregulated | Tretinoin results in decreased expression of EBNA1BP2 mRNA | 1p34.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ECE1 | 1889 |
upregulated | Tretinoin results in increased expression of ECE1 mRNA | 1p36.12 | |
| Tretinoin | Approved Investigational Nutraceutical | ECE2 | 9718 |
downregulated | Tretinoin results in decreased expression of ECE2 mRNA | 3q27.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ECEL1 | 9427 |
upregulated | Tretinoin results in increased expression of ECEL1 mRNA | 2q37.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ECHDC1 | 55862 |
upregulated | Tretinoin results in increased expression of ECHDC1 mRNA | 6q22.33 | |
| Tretinoin | Approved Investigational Nutraceutical | ECHDC2 | 55268 |
upregulated | Tretinoin results in increased expression of ECHDC2 mRNA | 1p32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ECHDC3 | 79746 |
downregulated | Tretinoin results in decreased expression of ECHDC3 mRNA | 10p14 | |
| Tretinoin | Approved Investigational Nutraceutical | ECI1 | 1632 |
upregulated | Tretinoin results in increased expression of ECI1 mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ECI2 | 10455 |
downregulated | Tretinoin results in decreased expression of ECI2 mRNA | 6p25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EDIL3 | 10085 |
upregulated | Tretinoin results in increased expression of EDIL3 mRNA | 5q14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EDN1 | 1906 |
upregulated | Tretinoin results in increased expression of EDN1 mRNA | 6p24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EDN2 | 1907 |
upregulated | Tretinoin results in increased expression of EDN2 mRNA | 1p34.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EDNRA | 1909 |
downregulated | Tretinoin results in decreased expression of EDNRA mRNA | 4q31.22-q31.23 | |
| Tretinoin | Approved Investigational Nutraceutical | EDNRA | 1909 |
upregulated | Tretinoin results in increased expression of EDNRA mRNA | 4q31.22-q31.23 | |
| Tretinoin | Approved Investigational Nutraceutical | EDNRB | 1910 |
downregulated | Tretinoin results in decreased expression of EDNRB mRNA | 13q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EDRF1 | 26098 |
downregulated | Tretinoin results in decreased expression of EDRF1 mRNA | 10q26.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EEF1A1 | 1915 |
downregulated | Tretinoin results in decreased expression of EEF1A1 mRNA | 6q13 | |
| Tretinoin | Approved Investigational Nutraceutical | EEF1A1 | 1915 |
upregulated | Tretinoin results in increased expression of EEF1A1 mRNA | 6q13 | |
| Tretinoin | Approved Investigational Nutraceutical | EEF1A2 | 1917 |
downregulated | Tretinoin results in decreased expression of EEF1A2 mRNA | 20q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | EEF1B2P5 | 442227 |
downregulated | Tretinoin results in decreased expression of EEF1B2P5 mRNA | 6q12 | |
| Tretinoin | Approved Investigational Nutraceutical | EEF1E1 | 9521 |
downregulated | Tretinoin results in decreased expression of EEF1E1 mRNA | 6p24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EEF1G | 1937 |
downregulated | Tretinoin results in decreased expression of EEF1G mRNA | 11q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EEF2KMT | 196483 |
downregulated | Tretinoin results in decreased expression of EEF2KMT mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EFCAB2 | 84288 |
upregulated | Tretinoin results in increased expression of EFCAB2 mRNA | 1q44 | |